Viewing data from:

CEPHALEXIN

ANDA

CEPHALEXIN | A090836 | ALKEM LABORATORIES LTD

4 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 14 NDCs

Highest NADAC/Unit

$5.18

per ea

Lowest NADAC/Unit

$0.0953

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
67877025523CEPHALEXIN 750 MG CAPSULE	$5.18	EA	Generic	—	2026-06-17
67877025520CEPHALEXIN 750 MG CAPSULE	$5.18	EA	Generic	—	2026-06-17
00904733761CEPHALEXIN 500 MG CAPSULE	$0.1217	EA	Generic	—	2026-06-17
67877021905CEPHALEXIN 500 MG CAPSULE	$0.1217	EA	Generic	—	2026-06-17
50268015215CEPHALEXIN 500 MG CAPSULE	$0.1217	EA	Generic	—	2026-06-17
62135071174CEPHALEXIN 500 MG CAPSULE	$0.1217	EA	Generic	—	2026-06-17

Showing 6 of 14 NDCs.

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 12 NDCs (12 FSS)

Lowest Price

$10.36

Highest Price

$69.94

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
63629-8855-01CEPHALEXIN 250MG CAP	$51.84	FSS	Bryant Ranch PrePack DBA Bryant Ranch PrePack	04/30/2026
63629-8856-01CEPHALEXIN 500MG CAP	$69.94	FSS	Bryant Ranch PrePack DBA Bryant Ranch PrePack	04/30/2026
63629-8854-01CEPHALEXIN 250MG CAP	$10.36	FSS	Bryant Ranch PrePack DBA Bryant Ranch PrePack	04/30/2026
72162-1830-01CEPHALEXIN 500MG CAP	$13.99	FSS	Bryant Ranch PrePack DBA Bryant Ranch PrePack	04/30/2026
72162-1830-02CEPHALEXIN 500MG CAP	$69.94	FSS	Bryant Ranch PrePack DBA Bryant Ranch PrePack	04/30/2026
72162-1830-05CEPHALEXIN 500MG CAP	$69.94	FSS	Bryant Ranch PrePack DBA Bryant Ranch PrePack	04/30/2026

Showing 6 of 12 NDCs.

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain8 active DMFs21 inactive

6 active API suppliers hold Drug Master Files for this ingredient.

CENTRIENT PHARMACEUTICALS NETHERLANDS BVCEPHALEXIN MONOHYDRATE

DMF 132101998

ANTIBIOTICOS SACEPHALEXIN MONOHYDRATE

DMF 135881998

ACS DOBFAR SPACEPHALEXIN MONOHYDRATE

DMF 136121998

ORCHID PHARMA LTDCEPHALEXIN USP

DMF 151062000

LUPIN LTDCEPHALEXIN USP

DMF 172772004

APITORIA PHARMA PRIVATE LTDCEPHALEXIN USP

DMF 176042004

APITORIA PHARMA PRIVATE LTDCEPHALEXIN USP (ENZYMATIC ROUTE)

DMF 329302019

LUPIN LTDCEPHALEXIN USP (ENZYMATIC)

DMF 413572025

GLAXO LABORATORIES SAInactiveCEPHALEXIN

DMF 18201971

ELANCO QUIMICA LIMITADAInactiveCEPHALEXIN DISOLVATE

DMF 98891992

LILLY RESEARCH LABORATORIESInactiveCEPHALEXIN MONOHYDRATE

DMF 133851998

LARKInactiveCEPHALEXIN MONOHYDRATE

DMF 135191998

ISFInactiveCEPHALEXIN MONOHYDRATE

DMF 135341998

ANTIBIOTICOSInactiveCEPHALEXIN MONOHYDRATE

DMF 135641998

DISTA PRODUCTS CO DIV ELI LILLY AND COInactiveCEPHALEXIN

DMF 136101998

YOSHITOMI PHARMACEUTICAL INDUSTRIES LTDInactiveCEPHALEXIN

DMF 137151998

TEVA PHARMACEUTICAL INDUSTRIES LTDInactiveCEPHALEXIN

DMF 137191998

SQUIBB GInactiveCEPHALEXIN

DMF 137201998

BRISTOL MYERS SQUIBB COInactiveCEPHALEXIN

DMF 137231998

BENZEX LABORATORIES LTDInactiveCEPHALEXIN

DMF 137331998

BIOCHEMIE SAInactiveCEPHALEXIN

DMF 137471998

LUPIN LTDInactiveCEPHALEXIN

DMF 137521998

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveCEPHALEXIN USP

DMF 137591998

TAIWAN BIOTECH CO LTDInactiveCEPHALEXIN

DMF 137811998

JK DRUGS AND PHARMACEUTICALS LTDInactiveCEPHALEXIN USP

DMF 142661999

LILLY RESEARCH LABORATORIES DIV ELI LILLY AND COInactiveCEPHALEXIN MONOHYDRATE BULK

DMF 149202000

UNIMARK REMEDIES LTDInactiveCEPHALEXIN USP

DMF 183612005

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveCEPHALEXIN USP (COMPACTED)

DMF 191622006

YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTDInactiveCEPHALEXIN USP "YUNG SHIN"

DMF 238722010

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (4)

Sort:

#001 — EQ 250MG BASE

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Dec 20, 2010

No patent or exclusivity listings for this strength.

#002 — EQ 500MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Dec 20, 2010

#003 — EQ 333MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Mar 29, 2013

#004 — EQ 750MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Mar 29, 2013